Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 3479-3484, September 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wold, W. S. M.
Right arrow Articles by Green, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wold, W. S. M.
Right arrow Articles by Green, M.

Analysis of Human Cancer DNA's for DNA Sequences of Human Adenovirus Serotypes 3, 7, 11, 14, 16, and 21 in Group B1

William S. M. Wold2, Jesse K. Mackey, Patricia Rigden and Maurice Green3

Institute for Molecular Virology, St. Louis University School of Medicine, St. Louis, Missouri 63110

We have investigated whether Group B human adenoviruses (Ad) (Ad3, Ad7, Ad11, Ad14, Ad16, and Ad21), which are widespread in the human population and are tumorigenic in hamsters, may play a role in human cancer. Hybridization of Ad7-radiolabeled DNA with DNA's from an Ad7-induced primary hamster tumor and from two cell lines (5728 and Ad7 P-cell) established from Ad7-induced hamster tumors indicated multiple copies per cell of 17, 30 to 36, and 20%, respectively, of the Ad7 genome. Thus, cells transformed by Group B Ads resemble cells transformed by Group C and Group A Ad's in that they retain multiple copies of a variable fraction of the viral genome. These model studies suggest that possible Group B Ad-induced human cancer cells should contain one or more copies of virus DNA per cell. Therefore, we assayed human cancer DNA's for Ad sequences, by highly sensitive "saturation-hydridization" reactions with Ad7 or Ad11 DNA (4 x 106 to 2.1 x 108 cpm/µg). We concentrated on cancers of the respiratory and digestive systems, because these systems are the most common sites of infection by Group B Ad's. In 8 independent experiments, no Ad7 sequences were detected in DNA's from 16 normal lung tissues, 18 normal tissues of the digestive system, 34 cancers of the respiratory system, 19 cancers of the digestive system, 11 cancers of the urinary system, 5 cancers of the genital system, 3 cancers of the breast, and 6 Hodgkin's lymphomas. Reconstruction controls with added Ad7 DNA indicated that about 0.05 to 0.1 copy of Ad7 DNA per cell should be detected. Ad11 is strongly implicated as a cause of acute hemorrhagic cystitis. In two independent experiments, no Ad11 sequences were detected in DNA's from 9 carcinomas of bladder, 10 carcinomas of prostate, 24 carcinomas of kidney, 3 hypemephromas, 3 Wilms' tumors, or 2 normal kidneys. Reconstruction experiments indicated that the cancer DNA assays had a sensitivity of 0.05 to 0.1 copy of Ad11 DNA per cell. The DNA's of Group B Ad's are >85% homologous by hybridization; thus, these results are applicable to all Group B serotypes. Our data provide evidence (but not formal proof) that none of the human cancers that we analyzed were induced by Group B Ad's. These tumors represent about 50% of the tumors that affect humans. The possible involvement of Group B Ad's in other less common forms of human cancers is under investigation in our laboratory.

1 This work was supported by Contract N01 CP 43359 from the Virus Cancer Program within the National Cancer Institute and by Contract 223-74-1022 from the Bureau of Biologics, Food and Drug Administration.

2 To whom requests for reprints should be addressed.

3 Recipient of USPHS Research Career Award 5K6-AI4739 from the National Institute of Allergies and Inflectious Diseases.

Received 9/15/78. Accepted 5/31/79.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
Q. Zhang, X. Su, S. Gong, Q. Zeng, B. Zhu, Z. Wu, T. Peng, C. Zhang, and R. Zhou
Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China
J. Gen. Virol., June 1, 2006; 87(6): 1531 - 1541.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
D. Metzgar, M. Osuna, S. Yingst, M. Rakha, K. Earhart, D. Elyan, H. Esmat, M. D. Saad, A. Kajon, J. Wu, et al.
PCR Analysis of Egyptian Respiratory Adenovirus Isolates, Including Identification of Species, Serotypes, and Coinfections
J. Clin. Microbiol., November 1, 2005; 43(11): 5743 - 5752.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Stone, S. Ni, Z.-Y. Li, A. Gaggar, N. DiPaolo, Q. Feng, V. Sandig, and A. Lieber
Development and Assessment of Human Adenovirus Type 11 as a Gene Transfer Vector
J. Virol., April 15, 2005; 79(8): 5090 - 5104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.